FDA Moves to Ban Common Decongestant in Cold Medicines

The FDA has proposed ending the use of oral phenylephrine, a common ingredient in many over-the-counter cold and allergy medications, after determining it is ineffective as a nasal decongestant. This decision follows a unanimous conclusion by FDA advisors and could lead to the removal of products like NyQuil and Sudafed from shelves, impacting sales and requiring drugmakers to reformulate their products. The proposal is not based on safety concerns, and the final decision is pending.